Patient Experience Across Dental Implant Drilling Protocols

November 11, 2026 updated by: RAQUEL GONZÁLEZ MARTÍNEZ, Cardenal Herrera University

Comparative Analysis of Patient Experience Among Under-drilling and Conventional Drilling in Dental Implants: a Randomized Double-blinded Study.

The goal of this clinical trial is to learn whether the drilling technique used to prepare the implant site affects the experience and satisfaction of adult patients receiving dental implants. The main questions it aims to answer are:

  • Do patients treated with under-drilling report a different experience, satisfaction and postoperative discomfort than patients treated with conventional drilling?
  • How are implant insertion torque, implant stability and bone density related to the pain and experience reported by patients?

Researchers will compare under-drilling (the implant site is prepared with a slightly narrower final drill than usual) with conventional drilling (the standard drilling sequence for the implant diameter). Both are standard clinical techniques.

Participants will:

  • Be randomly assigned to one of the two techniques, without knowing which one they receive
  • Have their dental implant(s) placed at the CEU Cardenal Herrera University Dental Clinic
  • Complete a questionnaire about their experience before surgery and immediately after surgery
  • Record their experience every day during the first week after surgery
  • Complete a quality-of-life questionnaire (OHIP-14) one week after surgery

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Study design: Single-center, randomized, double-blind, parallel-group clinical trial with two arms (1:1 allocation). Although the ethics committee-approved protocol describes the study as a randomized double-blinded cohort observational study, participants are randomly allocated to one of two standard implant site preparation techniques; the study is therefore registered as interventional according to ClinicalTrials.gov definitions. No experimental products are used.

Randomization and blinding: A computer-generated random sequence, stratified by age and sex, will be prepared before the start of the study and kept concealed. The surgeon will be informed of the allocated technique only at the time of surgery. Participants and the statistician performing the data analysis will remain blinded to group allocation.

Surgical procedure: All procedures will be performed under local anesthesia (4% articaine with 1:100,000 epinephrine) using a crestal mucoperiosteal incision and saline irrigation. In both groups, the osteotomy starts with a lanceolate drill and a 2 mm pilot drill to the planned length. In the under-drilling group, the drilling sequence stops at the drill prior to the standard final drill for the implant diameter; in the conventional group, the manufacturer's standard sequence is completed. Nobel Biocare or 3i implants will be used. Insertion torque will be recorded with the surgical motor and implant stability (ISQ) will be measured after placement. Bone density will be classified according to Misch (D1-D4) using preoperative 3D imaging and intraoperative assessment.

Perioperative care (identical in both groups): 0.12% chlorhexidine mouthwash before and after surgery, antibiotic prophylaxis and postoperative antibiotic treatment (amoxicillin, or azithromycin in penicillin-allergic patients), dexketoprofen as anti-inflammatory, and paracetamol 1 g as rescue analgesic.

Data collection: Sociodemographic and anthropometric data (age, sex, education level, employment status, weight, height and medication use) will be recorded. Patient experience will be assessed with an 11-item visual analogue scale (0-100 mm) before surgery, immediately after surgery and daily during the first 7 postoperative days. Oral health-related quality of life will be assessed with the OHIP-14 at day 7.

Sample size: Based on an estimated standard deviation of 1.5 and a minimum clinically important difference of 1.17, with alpha = 0.05 and 80% power, 26 participants per group are required (52 in total). Allowing for losses, 62 participants will be enrolled.

Statistical analysis: Independent t-tests, Pearson's chi-square and Fisher's exact tests will be used, with a significance level of 5%.

Study Type

Interventional

Enrollment (Estimated)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Valencia
      • Alfara del Patriarca, Valencia, Spain, 46115
        • Clínica Odontológica Universitaria, Universidad CEU Cardenal Herrera
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 years or older
  • Partially or completely edentulous patients requiring dental implant placement
  • Signed informed consent

Exclusion Criteria:

  • Use of psychotropic or pain-modulating medication
  • Systemic conditions affecting bone healing
  • Use of medication known to interfere with bone metabolism
  • Pregnancy or breastfeeding
  • Allergy or intolerance to implant materials (e.g., titanium, zirconia)
  • Severe bruxism or severe temporomandibular joint (TMJ) disorders
  • Inability to follow postoperative care protocols or maintain basic oral hygiene
  • Psychological or cognitive impairment that may interfere with understanding or following postoperative care instructions
  • Inability to attend follow-up visits
  • Previous implant failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Under-drilling (UD)

Participants receive dental implant(s) placed using the under-drilling technique.

Implant site preparation with a lanceolate drill and a 2 mm pilot drill to the planned length, followed by the manufacturer's drilling sequence stopping at the drill prior to the standard final drill for the implant diameter, with saline irrigation. Nobel Biocare or 3i implants are placed and insertion torque is recorded.

Active Comparator: Conventional drilling (CO)

Participants receive dental implant(s) placed using the conventional drilling technique.

Implant site preparation with a lanceolate drill and a 2 mm pilot drill to the planned length, followed by the manufacturer's complete standard drilling sequence for the implant diameter, with saline irrigation. Nobel Biocare or 3i implants are placed and insertion torque is recorded.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Experience and Satisfaction (Visual Analogue Scale)
Time Frame: Preoperatively (baseline), immediately after surgery, and daily on postoperative days 1 to 7

Patient experience with the treatment assessed with an 11-item visual analogue scale (VAS). Each item is scored on a 100 mm line (0 = low, 50 = moderate, 100 = extreme). Higher scores indicate greater intensity of the assessed experience.

Preoperatively (baseline), immediately after surgery, and daily on postoperative days 1 to 7

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral Health-Related Quality of Life (OHIP-14)
Time Frame: 7 days after surgery

Oral Health Impact Profile-14 questionnaire, covering 7 dimensions (functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability and handicap) with 2 items each. Total score range 0-56; higher scores indicate worse oral health-related quality of life.

7 days after surgery
Implant Stability Quotient (ISQ)
Time Frame: During surgery (day 0)

Primary implant stability measured by resonance frequency analysis immediately after implant placement (ISQ units, 1-100; higher values indicate greater stability).

During surgery (day 0)
Implant Survival
Time Frame: 7 days after surgery

Presence of the implant in situ without mobility, pain or signs of infection requiring removal.

7 days after surgery
Implant Insertion Torque
Time Frame: During surgery (day 0)

Insertion torque (Ncm) recorded by the surgical motor (OsseoSet 300) at implant placement.

During surgery (day 0)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone Density (Misch Classification)
Time Frame: Preoperatively and during surgery (day 0)

Bone density at the implant site classified as D1-D4 according to Misch, assessed on preoperative 3D imaging and confirmed intraoperatively during drilling.

Preoperatively and during surgery (day 0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: RAQUEL GONZÁLEZ-MARTÍNEZ, DDS, MSc, PhD, Cardenal Herrera University
  • Principal Investigator: ISIDORO CORTELL-BALLESTER, MD, DDS, MSc, PhD, Cardenal Herrera University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

November 11, 2026

First Submitted That Met QC Criteria

November 11, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 11, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • CEEI25_699

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared. In accordance with the protocol approved by the ethics committee and with the EU General Data Protection Regulation (GDPR) and Spanish Organic Law 3/2018, access to the data is restricted to the research team, and the data will be destroyed after publication of the results.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.